Hearing Loss Trial, Recruiting (NCT03511807)

Hearing Loss Trial, Recruiting NCT03511807 Sponsor: University of California, Irvine Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT03511807 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You are any gender (male or female)
You have had ringing or noise in your ears (tinnitus) for 6 months or longer
You can understand and speak English well enough to describe sensations and fill out surveys
If the trial involves using a cochlear implant (a device implanted in the ear), you must already have one before joining this part of the study (this does not apply if you are in the sound-based treatment group)

Who may not be able to join:

You are under 18 years old
You currently use illegal drugs or are dependent on alcohol
Your tinnitus has a cause that can be treated (confirm with trial site)
You have a history of psychosis (a serious mental health condition affecting how you perceive reality)
You have physical problems with your ear canal or eardrum
You have a long-term disease affecting your middle ear
You are taking certain pain-relief medications such as aspirin, ibuprofen, or naproxen that are known to cause tinnitus, and you are unable to stop taking them
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03511807

Sponsor: University of California, Irvine

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

More information: https://clinicaltrials.gov/study/NCT03511807

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You are any gender (male or female)
You have had ringing or noise in your ears (tinnitus) for 6 months or longer
You can understand and speak English well enough to describe sensations and fill out surveys
If the trial involves using a cochlear implant (a device implanted in the ear), you must already have one before joining this part of the study (this does not apply if you are in the sound-based treatment group)

Who may not be able to join:

You are under 18 years old
You currently use illegal drugs or are dependent on alcohol
Your tinnitus has a cause that can be treated (confirm with trial site)
You have a history of psychosis (a serious mental health condition affecting how you perceive reality)
You have physical problems with your ear canal or eardrum
You have a long-term disease affecting your middle ear
You are taking certain pain-relief medications such as aspirin, ibuprofen, or naproxen that are known to cause tinnitus, and you are unable to stop taking them
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, Irvine

Registry

ClinicalTrials.gov

Start date

1 January 2017

Est. completion

1 November 2032

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Audiogram; Otoacoustic Emissions (OAE); Tinnitus Handicap Inventory (THI); Medical Outcomes Study Questionnaire Short Form 36 (SF-36) Health Survey Quality of life metrics.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov